94217 ⎘
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms; Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom Oxygen atoms
Sub-classes:HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN
#2NOVEL COMPOUND EXHIBITING THERAPEUTIC EFFECT ON INFLAMMATORY DISEASE AS P38 MAP KINASE INHIBITOR
#3COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY
#4COMPOUNDS AND METHODS
#5FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS
#6CLEAVABLE AGENTS
#7INHIBITORS OF THE N-TERMINAL DOMAIN OF THE ANDROGEN RECEPTOR
#8OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS AND SKIN DISEASES
#9Curing accelerator for oxidatively polymerized unsaturated resin, printing ink, and paint
#10Cleavable agents
#11Glucosylceramide synthase inhibitors for the treatment of diseases
#12Nitrogen-containing heteroaryl compound and pharmaceutical use thereof
#13Synthesis of hypervalent iodine reagents with dioxygen
#14Sulfamate derivative compounds, processes for preparing them and their uses
#15N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
#16Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#17Anticancer compounds
#18N-ACYLOXYSULFONAMIDE AND N-HYDROXY-N-ACYLSULFONAMIDE DERIVATIVES
#19Benzenesulfonamide upregulators of NPC1 for Neimann-Pick disease and other lysosomal storage disorders
#20N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
#21Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#22Glucosylceramide synthase inhibitors for the treatment of diseases
#23Substituted pyridines as sodium channel blockers
#24STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI
#25Pyridine compounds and the uses thereof
#26N-substituted pyridinylidenes for combating animal pests
#27Substituted pyridines as sodium channel blockers
#28Process for the synthesis of etoricoxib
#29Functionalizing reagents and their uses
#30N-ACYLOXYSULFONAMIDE AND N-HYDROXY-N-ACYLSULFONAMIDE DERIVATIVES
#31CCR9 inhibitors and methods of use thereof
#32Aminopropenoates as Fungicides
#33COMPOUNDS AND THERAPEUTIC USES THEREOF
#34Pyridine compounds and the users thereof
#35Aryl pyridine as aldosterone synthase inhibitors
#36Organic compound
#37Aryl pyridine as aldosterone synthase inhibitors
#38Pyridine derivatives with umami flavour
#39Acrylamide derivative and use thereof in manufacture of medicament
#40Functionalising reagents and their uses
#41Herbicides
#42RESIST COMPOSITION FOR SEMICONDUCTOR, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME
#43CCR9 inhibitors and methods of use thereof
#44Peptidic compounds
#45Method for manufacturing heterocycle substituted pyridine derivatives
#46Organic compound
#47ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS
#48Aminopropenoates as fungicides
#49N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives
#50FUNGICIDAL PYRIDINES
#51Hydrazone Compounds and Their Use
#52CCR9 INHIBITORS AND METHODS OF USE THEREOF
#53Aryl pyridine as aldosterone synthase inhibitors
#54CCR9 inhibitors and methods of use thereof
#55Imaging agents for protein misfolding
#56Histone deacetylases inhibitors
#57Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
#58TRANS-1,2-DIPHENYLETHLENE DERIVATIVES AND NANOSENSORS MADE THEREFROM
#59CCR9 inhibitors and methods of use thereof
#60CCR9 inhibitors and methods of use thereof
#61Peptidic compounds
#62CCR9 inhibitors and methods of use thereof
#63Histone deacetylases inhibitors
#64CCR9 inhibitors and methods of use thereof
#65CCR9 inhibitors and methods of use thereof